Intraperitoneal aerosolization of bupivacaine is a safe and effective method in controlling postoperative pain in laparoscopic Roux-en-Y gastric bypass by Alkhamesi, Nawar A et al.
© 2008 Alkhamesi et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access 
article which permits unrestricted noncommercial use, provided the original work is properly cited.
Journal of Pain Research 2008:1 9–13 9
ORIGINAL RESEARCH
Intraperitoneal aerosolization of bupivacaine 
is a safe and effective method in controlling 
postoperative pain in laparoscopic Roux-en-Y 
gastric bypass
Nawar A Alkhamesi1
James M Kane, Jr2
Paul J Guske2
Jonathan W Wallace2
Peter C Rantis, Jr2
1Department of Biosurgery
and Technology, Imperial College 
London, UK; 2Department of Surgery, 
Alexian Brothers Hospital Network, 
Chicago, USA
Correspondence: Nawar A Alkhamesi
Department of Biosurgery
and Technology, Imperial College London, 
10th Floor, QEQM Wing, St. Mary’s 
Hospital, Praed Street, London W2
1NY, UK
Tel +44 20 7886 6119
Fax +44 20 7886 1810
Email n.alkhamesi@imperial.ac.uk
Introduction: Obesity is a worldwide problem and has grown in severity in the last few decades 
making bariatric surgery and, in particular, laparoscopic banding and Roux-en-Y gastric bypass 
efﬁ  cacious and cost-effective procedures. The laparoscopic approach has been shown to offer 
signiﬁ  cant healthcare beneﬁ  ts, of particular interests are reports of decreased postoperative 
pain resulting in a shorter hospital stay and an earlier return to normal activity. However, many 
patients still experience signiﬁ  cant pain, including shoulder tip pain, that require strong analgesia 
including opiates during their early recovery period. The aims of this study were to establish 
the safe use of the aerosolization technique in bariatric surgery and to investigate the possible 
beneﬁ  ts in reducing postoperative pain.
Methods: In this study, ﬁ  fty patients undergoing laparoscopic gastric bypass were recruited and 
divided into two groups; control (n = 25) and therapeutic (n = 25). The control group received 
intraperitoneal aerosolization of 10 mL of 0.9% normal saline while the therapeutic group 
received 10 mL of 0.5% bupivacaine. All the patients had standard preoperative, intraoperative, 
and postoperative care. Pain scores were carried out by the nursing staff in recovery and 6 h, 
12 h and 24 h postoperatively using a standard 0–10 pain scoring scale. In addition, opiate 
consumption via patient-controlled analgesia (PCA) was recorded.
Results: Aerosolized bupivacaine reduced postoperative pain in comparison to normal saline 
(p  0.05). However, PCA usage showed no statistically signiﬁ  cant change from the control 
group.
Conclusion: The aims of this study were achieved and we were able to establish the safe use 
of the aerosolization technique in bariatric surgery and its beneﬁ  ts in reducing postoperative 
pain.
Keywords: laparoscopy, aerosolization, Roux-en-Y gastric bypass, bupivacaine, local 
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Introduction
Obesity is a worldwide problem and has grown in severity in the last few decades (Elder 
and Wolfe 2007). This disease will have a signiﬁ  cant impression on patients’ health and 
the economy making bariatric surgery and in particular laparoscopic banding (LAGB) 
and Roux-en-Y gastric bypass (LRYGB) efﬁ  cacious and cost-effective procedures 
(Frezza et al 2007; Hawkins et al 2007). The laparoscopic approach has been shown 
to offer signiﬁ  cant health care beneﬁ  ts, of particular interest are reports of decreased 
postoperative pain resulting in a shorter hospital stay and an earlier return to normal 
activity. However, many patients still experience signiﬁ  cant pain, including shoulder 
tip pain, that require strong analgesia including opiate during their early recovery 
period (Dixon et al 2005; Madan et al 2005).Journal of Pain Research 2008:1 10
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Intraperitoneal anesthetics have been studied in LRYGB 
and the results showed a noticeable reduction in narcotic 
use with no clear effect on postoperative pain (Symons et al 
2007). This ﬁ  nding emphasizes the fact that post-laparoscopic 
pain is a multifactorial phenomenon and requires a global 
approach. The author (NA Alkhamesi) has been involved in 
developing an aerosolization system that utilizes the unique 
laparoscopic environment, a closed and pressurized system, 
to deliver intraperitoneal medications in an aerosol form, 
which will guarantee the uniform coverage of the entire 
peritoneal cavity in order to achieve maximum therapeutic 
beneﬁ  ts (Alkhamesi et al 2005). This technology has been 
shown to be successful in the treatment of post-laparoscopic 
pain following laparoscopic cholecystectomy using an 
aerosolized bupivacaine (Alkhamesi et al 2007).
The aims of this study were to establish the safe 
use of the aerosolization technique in bariatric surgery 
and to investigate the possible benefits in reducing 
postoperative pain.
Material and method
This is a prospective randomized double-blinded clinical 
trial that was approved by the Institutional Review Board 
and was carried out at Alexian Brothers Hospital Network, 
Chicago, USA. All the patients gave informed consent and 
were provided with an information booklet, which described 
the study in detail along with the possible risk factors.
Patient selection
We recruited 50 patients on a voluntary basis who underwent 
elective laparoscopic Roux-en-Y gastric bypass (LRYGB) at 
the Alexian Brothers Hospital, Chicago, USA The inclusion 
criteria included patients between the age of 18–65 years, and 
American Society of Anesthesiology (ASA) scores I, II, 
and III. We excluded patients below the age of 18 and those 
with known allergies to bupivacaine or any other drugs used 
during anesthesia or in the postoperative pain management 
protocol. We also excluded patients with ASA IV, patients 
with history of drug abuse, and those who used narcotic drugs 
within 30 days of their procedure.
Study design
All the patients, junior medical staff and the nursing staff 
in recovery and the wards were blinded to the study. The 
operating surgeons and the anesthetist were aware of the 
study protocol, but were blinded to contents of the aerosol 
or the injected solutions. The 50 patients were randomly 
divided into 2 groups of twenty-ﬁ  ve; the Control group 
(received 10 mL of aerosolized intraperitoneal 0.9% normal 
saline), and the Treatment group (received 10 mL, equivalent 
to 50 mg of aerosolized 0.5% plain bupivacaine).
The two groups had the same anaesthetic protocol. 
Pre-operatively patients received fentanyl 50–100 μg/kg 
and midazolam 0.07 mg/kg intravenously. Anesthetic 
induction was achieved by using 1 μg/kg fentanyl and 
propofol 2–3 mg/kg. Perioperatively, the patients received 
a mixture of air and oxygen with sevoﬂ  urane to maintain 
anesthesia, in addition, pre-incision 50 μg/kg of morphine 
was given intravenously. Muscle relaxation was achieved 
using 0.5 mg/kg rocuronium.
Experienced laparoscopic surgeons (JK, PG, JW, and 
PR), using the same surgical technique standardized by the 
Department of Surgery at the Alexian Brothers Hospital, 
performed the operations. A classic 6-ports procedure 
was utilized to perform the operation. Pneumoperitoneum 
was achieved using nonhumidiﬁ  ed CO2 at a pressure of 
15 mmHg. The medial left upper quadrant trocar site was 
dilated during the procedure to facilitate the introduction of 
a size 21 circular stapler (Ethicon, USA). This site was also 
used to insert the intraperitoneal drain. At the end of the 
procedure and before ports withdrawal, the intraperitoneal 
therapeutic was introduced followed by wound closure and 
the injection of 30 mL of 0.5% bupivacaine with epinephrine 
(150 mg of bupivacaine) into the 6 wounds in all the par-
ticipant patients. The dose of bupivacaine was calculated at 
2 mg/Kg body weight and did not exceed 210 mg in total for 
each patient in line with the recommended dosage to avoid 
any adverse effects.
Postoperative pain management included giving all 
patients a patient-controlled analgesia (PCA) containing 
dilaudid or morphine.
The pain was scored by trained nursing staff in recovery, 
6 h, 12 h, and 24 h postoperatively using a simple 0–10 scale 
where 0 is no pain while 10 is the worst pain experienced 
by the patients.
Intraperitoneal aerosolization technique
The local anesthetic and the normal saline were delivered 
intraoperatively before ports withdrawal and wound closure 
using the intraperitoneal aerosolization technique developed 
previously by the author, NA Alkhamesi (Alkhamesi et al 
2005, 2007). In brief, it is a syringe drive integrated with a 
gas insufﬂ  ator and uses a specially designed multi-lumen 
catheter that can be introduced into the abdomen through 
any port using a special introducer to prevent gas leakage 
(Figure 1). This system enables the operator to deliver the Journal of Pain Research 2008:1 11
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desired therapeutic dose while employing the smallest 
possible volume.
In this study, the surgeons were able to aerosolize either 
10 mL of 0.5% bupivacaine or 10 mL of 0.9% normal 
saline at a controlled speed of 3.5 mL/min. This delivery 
method generated a “foggy” environment to ensure that the 
intraperitoneal space was covered completely.
Statistical analysis
Analysis of variance (ANOVA) was used to compare 
multiple group means. Differences between individual groups 
were examined using post hoc analysis (Tukey-Kramer test). 
SPSS™ 11.5 for Windows™ (SPSS Inc., Chicago, IL, USA) 
was utilized to perform all statistics. All data are presented 
as the mean ± standard error of the mean (SEM). A p value 
of less than 0.05 was taken to be signiﬁ  cant.
Results
In this study, 50 patients were recruited with mean age 
of 43 years (range, 21–65 years). There were 35 females 
and 15 males with an average body mass index (BMI) of 
51.95 (range, 34.1–69.8). They were divided into two groups. 
The control group (N = 25) had 17 females and 8 males with 
mean age of 46.3 years (range, 26–65 years) and the average 
BMI was 50.2 (range, 35.9–69.8). The therapeutic group 
(N = 25) consisted of 18 females and 7 males with mean age 
of  41.2 years (range, 21–65 years).and the average BMI was 
47.1 (range, 34.1–68.9).
The aerosolization of 0.5% bupivacaine reduced 
postoperative pain including shoulder tip pain in comparison 
with the control group, p = 0.01, maximum reduction was 
in the recovery period and continued at all other given time 
(Figure 2). This reduction in pain severity was matched 
by a noticeable decrease in PCA usage in the therapeutic 
Figure 1 Intraperitoneal aerosolization device. The syringe drive on the right is 
connected to the insufﬂ  ator using a specially designed single use catheter (Green 
and White).
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Figure 2 The aerosolisation of 0.5% bupivacaine reduced postoperative pain in comparison with control. Trained nursing staff in recovery and the ward using a 0–10 scale 
recorded the pain severity.Journal of Pain Research 2008:1 12
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groups; however, it was not statistically signiﬁ  cance, p = 0.52 
(Figure 3).
All the patients were discharged home as planned 
and none of them suffered any side effects that might 
be associated with the aerosolization device or the 
bupivacaine used.
Discussion
Despite all the beneﬁ  ts that have come with the introduction 
of minimal invasive surgery, postoperative pain and, in 
particular, shoulder pain remains an issue.
Many studies have tried to address the notion of post-
laparoscopic pain; they exploited many methods including 
injecting the port site with local anesthetic, intraperitonal 
administration of normal saline or bupivavcaine (Liu et al 
1993; Alexander et al 1996; Michaloliakou et al 1996; Cunniffe 
et al 1998; Bar-Dayan et al 2004), and the use of warm and 
humidiﬁ  ed gas (Korell et al 1996; Huntington and LeMaster 
1997; Mouton et al 1999a, 2001). No techniques achieved a 
clear beneﬁ  t and the results were contradicting (Joris et al 1995; 
Deans et al 1998; Mouton et al 1999b; Ghezzi et al 2005).
Alkhamesi and colleagues have successfully used the 
aerosolazation technique in the management of postoperative 
pain following laparoscopic cholecystectomy (Alkhamesi et al 
2007). They showed that bupivacaine aerosol signiﬁ  cantly 
reduced pain in comparison to control and to the administration 
of local anesthetic in to the gall bladder bed.
In this study, we utilized a novel aerosolization 
system that has been proven to be successful in delivering 
intraperitoneal local anesthetics to treat postoperative 
pain. Patients in the therapeutic group had less pain at all 
measured time points compared to the control group and 
used their PCA less. Although the statistics did not show 
any signiﬁ  cant difference in the PCA usage, we believe 
that, this was because the patients were instructed, at their 
pre-operative consultation, to use their PCA regularly even 
if they had no pain. This fact might have a major effect on 
our study outcome and the investigators were not aware of 
it until they started analyzing the data.
Moreover, this study demonstrated that the aerosolization 
technique is safe in bariatric patients and can be used to 
deliver intraperitoneal therapeutics during laparoscopic 
procedures.
In conclusion, the aims of this study were achieved and 
we were able to establish the safe use of the aerosolization 
technique in bariatric surgery and identify its potential 
beneﬁ  ts for reducing postoperative pain. The authors believe 
that a better organized trial with higher numbers in each 
group is required to conﬁ  rm the status of this method of 
pain control in laparoscopic bariatric operations in order 
for it to become the standard technique. We also believe 
that this method of pain management can be used in other 
laparoscopic operations such as laparoscopic ventral hernia 
repair and laparoscopic colorectal resection.
Figure 3 The use of PCA was reduced in the therapeutic group in comparison with control. However, it did not reach statistical signiﬁ  cance in all measured time points.
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